StreetInsider.com News Articles

Form EFFECT Can-Fite BioPharma Ltd.

Tue, 13 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261013/27176261.html

Form EFFECT Can-Fite BioPharma Ltd.

Tue, 13 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261013/27176286.html

Form 424B3 Can-Fite BioPharma Ltd.

Fri, 09 Oct 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20261009/27172293.html

H.C. Wainwright Reiterates Buy Rating on Can-Fite BioPharma (CANF)

Tue, 29 Sep 2026 06:49:22 -0400

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $8.00 price target on Can-Fite BioPharma (NYSE: CANF).

The analyst commented: "Recently, Can-Fite reported 1H26 financial results and provided a corporate update. The company’s pivotal Phase 3 COMFORT study is evaluating piclidenoson, an oral A3 adenosine receptor (A3AR) agonist, in patients with moderate-to-severe plaque psoriasis. The randomized, double-blind trial assigns patients 2:1 to piclidenoson 3 mg BID or placebo, with co-primary efficacy objectives of PASI 75 and sPGA 0/1 at week 16. In July, the company completed enrollment of 247 patients for the prespecified interim analysis; the study’s registry entry lists

Form F-3 Can-Fite BioPharma Ltd.

Mon, 28 Sep 2026 13:54:00 -0400

si-local-file:///var/storage/secattach/20260928/27113307.html

Form F-3/A Can-Fite BioPharma Ltd.

Fri, 25 Sep 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260925/27107783.html

Form EFFECT Can-Fite BioPharma Ltd.

Mon, 14 Sep 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260914/27054881.html

Form EFFECT Can-Fite BioPharma Ltd.

Mon, 14 Sep 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260914/27054887.html

Form D Can-Fite BioPharma Ltd.

Thu, 10 Sep 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260910/27049247.html

Form 6-K Can-Fite BioPharma Ltd. For: Sep 09

Wed, 09 Sep 2026 07:02:00 -0400

si-local-file:///var/storage/secattach/20260909/27039156.html

Form POS AM Can-Fite BioPharma Ltd.

Tue, 08 Sep 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260908/27037157.html

Form POS AM Can-Fite BioPharma Ltd.

Tue, 08 Sep 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260908/27037164.html

Form 6-K Can-Fite BioPharma Ltd. For: Jun 30

Tue, 08 Sep 2026 08:22:00 -0400

si-local-file:///var/storage/secattach/20260908/27033724.html

Form 6-K Can-Fite BioPharma Ltd. For: Sep 03

Thu, 03 Sep 2026 11:44:00 -0400

si-local-file:///var/storage/secattach/20260903/27023616.html

Form 6-K Can-Fite BioPharma Ltd. For: Sep 02

Wed, 02 Sep 2026 09:06:00 -0400

si-local-file:///var/storage/secattach/20260902/27016553.html

Can-Fite reports longer survival in HCC trial than anticipated

Wed, 02 Sep 2026 07:07:41 -0400

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) announced that blinded overall survival observed across the entire patient population in its ongoing pivotal Phase III study of Namodenoson in advanced hepatocellular carcinoma (HCC) appears longer than originally anticipated based on the assumptions underlying the study design.

The Phase III study is a randomized, double-blind, placebo-controlled trial evaluating Namodenoson in patients with advanced HCC and underlying Child-Pugh B7 cirrhosis. Patients are randomized 2:1 to receive Namodenoson or placebo, with overall survival as the primary efficacy endpoint.

The company noted that the observed survival reflects the pooled, blinded study population and includes patients receiving

Form 6-K Can-Fite BioPharma Ltd. For: Sep 02

Wed, 02 Sep 2026 07:04:00 -0400

si-local-file:///var/storage/secattach/20260902/27015541.html

Form F-3 Can-Fite BioPharma Ltd.

Fri, 28 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260828/26998104.html

Form F-3 Can-Fite BioPharma Ltd.

Fri, 28 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260828/26998104.html

Form F-3 Can-Fite BioPharma Ltd.

Fri, 28 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260828/26998104.html

Form 6-K Can-Fite BioPharma Ltd. For: Aug 17

Mon, 17 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260817/26934755.html

Form 6-K Can-Fite BioPharma Ltd. For: Aug 17

Mon, 17 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260817/26934755.html

Form 6-K Can-Fite BioPharma Ltd. For: Aug 17

Mon, 17 Aug 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260817/26934755.html

Form 6-K Can-Fite BioPharma Ltd. For: Aug 12

Wed, 12 Aug 2026 07:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26908762.html

Form 6-K Can-Fite BioPharma Ltd. For: Aug 12

Wed, 12 Aug 2026 07:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26908762.html